192 related articles for article (PubMed ID: 3903379)
1. Mechanisms of action and clinical applications of cytotoxic drugs in rheumatic disorders.
Nashel DJ
Med Clin North Am; 1985 Jul; 69(4):817-40. PubMed ID: 3903379
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic drugs: their clinical application to the rheumatic diseases.
Clements PJ; Davis J
Semin Arthritis Rheum; 1986 May; 15(4):231-54. PubMed ID: 2872726
[No Abstract] [Full Text] [Related]
3. [Treatment of chronic diseases of connective tissue by cytostatic drugs].
Deicher H; Fricke R; Kruli P
Rev Clin Esp; 1970 Mar; 116(6):539-48. PubMed ID: 4996836
[No Abstract] [Full Text] [Related]
4. Immunosuppressive therapy in rheumatic disease.
Pirofsky B; Bardana EJ
Med Clin North Am; 1977 Mar; 61(2):419-37. PubMed ID: 16187
[No Abstract] [Full Text] [Related]
5. Azathioprine, cyclophosphamide and chlorambucil.
Luqmani RA; Palmer RG; Bacon PA
Baillieres Clin Rheumatol; 1990 Dec; 4(3):595-619. PubMed ID: 2093442
[TBL] [Abstract][Full Text] [Related]
6. [Immunosuppressive treatment of collagen diseases].
Cruchaud A
Ther Umsch; 1969 Dec; 26(12):697-702. PubMed ID: 5386688
[No Abstract] [Full Text] [Related]
7. Cytotoxic drugs in treatment of nonmalignant diseases.
Ann Intern Med; 1972 Apr; 76(4):619-42. PubMed ID: 4268240
[No Abstract] [Full Text] [Related]
8. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
Fox DA; McCune WJ
Concepts Immunopathol; 1989; 7():20-78. PubMed ID: 2676180
[No Abstract] [Full Text] [Related]
9. [Current aspects of immunosuppressive therapy of collagen diseases].
Marmont A; Rossi F; Bordo D
Minerva Med; 1973 Jun; 64(46):2436-50. PubMed ID: 4723570
[No Abstract] [Full Text] [Related]
10. Clinical use of immunosuppressive drugs: part I.
Gerber NL; Steinberg AD
Drugs; 1976; 11(1):14-35. PubMed ID: 770131
[TBL] [Abstract][Full Text] [Related]
11. [The immunosuppressive agents in rheumatology. Indications, results and problems of long-term surveillance].
Kahn MF; De Seze S
Ann Med Interne (Paris); 1974; 125(6-7):497-506. PubMed ID: 4216281
[No Abstract] [Full Text] [Related]
12. An approach to the use of immunosuppressive drugs in nonmalignant diseases.
Steinberg AD
J Allergy Clin Immunol; 1973 Oct; 52(4):242-50. PubMed ID: 4602869
[No Abstract] [Full Text] [Related]
13. Immunosuppressive drug therapy.
McCune WJ; Vallance DK; Lynch JP
Curr Opin Rheumatol; 1994 May; 6(3):262-72. PubMed ID: 8060760
[TBL] [Abstract][Full Text] [Related]
14. [Auto-immune diseases and immunodepressive therapy. II. Current clinical indications].
Delespesse G; Kennes B; Duchateau J
Acta Clin Belg; 1974; 29(6):413-23. PubMed ID: 4155218
[No Abstract] [Full Text] [Related]
15. Conventional treatment and outcome of Wegener's granulomatosis and microscopic polyangiitis.
Jayne DR
Cleve Clin J Med; 2002; 69 Suppl 2():SII110-5. PubMed ID: 12086249
[No Abstract] [Full Text] [Related]
16. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
De Jesus A; Talal N
Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive drugs in rheumatoid arthritis.
Baum J; Vaughan J
Ann Intern Med; 1969 Jul; 71(1):202-4. PubMed ID: 4892968
[No Abstract] [Full Text] [Related]
18. The clinical use of immunosuppressive drugs.
Forbes IJ
Med J Aust; 1973 Apr; 1(15):749-52. PubMed ID: 4707372
[No Abstract] [Full Text] [Related]
19. Azathioprine.
Ahmed AR; Moy R
Int J Dermatol; 1981 Sep; 20(7):461-7. PubMed ID: 7026466
[No Abstract] [Full Text] [Related]
20. Update on immunosuppressive therapy.
Singer NG; McCune WJ
Curr Opin Rheumatol; 1998 May; 10(3):169-73. PubMed ID: 9608317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
